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A 62-year-old Japanese man had been suffering from dysuria since January 2011. Since symptoms
persisted regardless of antibiotics therapy at a urological clinic, he consulted our clinic in February 2011.
Digital rectal examination revealed a large irregular and stony hard prostatic mass, with the serum prostated
specific antigen (PSA) of 2.76 ng/ml. T2-weighted magnetic reasonance imaging showed diffuse hypo-
intensity and sharp margin in prostatic peripheral zone. Transperineal biopsy of the prostate was performed
in March 2011. Considering histopathological findings of tumor cells in all specimens combined with
positive immunoreactivity of neoplastic cells to chromogranin A but negative immunoreactivity to PSA, we
diagnosed him with small cell carcinoma. The whole body computed tomography showed no metastatic
lesion, he was diagnosed with small cell carcinoma of the prostate at clinical stage T2cN0M0. He received 4
cycles of chemotherapy (cisplatinum and etoposide) and underwent external beam radiotherapy to the pelvis
and prostate, up to a total dose of 64 Gy. The urologic and radiologic outcomes including the serum levels
of neuron-specific enolase and pro-gastrin releasing peptide have been satisfactory after more than 3 years of
follow-up.
(Hinyokika Kiyo 60 : 645-650, 2014)







患 者 : 62歳，男性









硬，表面不整であった．しかし PSA は 2.76 ng/ml と
正常値であった．前立腺 MRI 検査にて前立腺被膜は
明瞭に認識できたが，両葉にわたり辺縁域・移行域と
















Fig. 1. a : T2-weighted MRI of prostate reveals
diffuse hypointensity throughout peripheral
zone of prostate at first presentation. b :







Fig. 2. a : Histopathological examinations showed
proliferation of small cells which had a high
nucleus-cytoplasm ratio (HE staining, 10X).
b : Tumor is diffusely positive for chromo-
granin (chromogranin A staining, 10X). c :
Histopathological examinations showed fib-
rosis in prostatic stroma (HE staining, 10X).
GRP 42. 1 pg/ml（正常値 80. 0 pg/ml 以下），血清









100 mg/m2 day 1∼3，cisplatin 80 mg/m2 day 1 (EP 療
法）を使用して同年 3月より28日を 1コースとして治








たが，有害事象共通用語基準 v 3.0 2007年 3月改訂版
(CTCAE v 3.0) におけるグレード 2にとどまるもの
であった．EP 療法 4コース終了後，同年 8月より骨
盤腔に 40 Gy の照射とその後前立腺と精嚢に対して
24 Gy を追加して総線量 64 Gy の放射線外照射療法を
施行した．
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Table 1. Clinical and pathological characteristics of
patients (n＝111)
Variable No ％







PSA at dianosis of SCC





Lower urinary tract symptoms 51 45.9
Lower abdominal or perineal pain 14 12.6
Macroscopic hematuria 17 15.3
















Local disease 10 9.0
Bladder neck 9 8.1
Retroperitoneal lymph nodes 13 11.7
Distant metastasis 58 52.3
Unknown 21 18.9
Treatment of SCC




Others or unknown 16 14.4








Fig. 3. a : Kaplan-Meier estimates of overall survi-
val rate of patients with small cell carcinoma
of the prostate in Japanese literature. b :
Kaplan-Meier estimates of overall survival
rate by chemotherapy. EP : VP-16＋CDDP
or CBDCA, IP : irinotecan ＋ CDDP or
CBDCA. EP or IP (＋) group : 21.4 month
(median), EP or IP (−) group : 15.8 month
(median). c : Kaplan-Meier estimate of overall
survival rate by radiotherapy. Rx : Radio-
therapy. Rx (＋) 25. 2 months (median),
Rx (−) 14.8 months (median).
その後の画像による全身検索にて新規病変は認めな
かったが，前立腺 MRI の T2 強調像では依然として
辺縁域において高信号な部位と低信号な部位が存在し
ていたため，局所の治療効果判定目的で2012年 2月前
立腺再生検を施行した．生検標本には viable cell は認
めず病理学的癌治療効果 3b との結果であった (Fig.
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Age at diagnosis of SCC
21-50 vs 51-60 vs 61-70 vs 70-85 0.33
PSA at diagnosis of SCC
With normal range vs 4-20 vs 20- 0.51
Clinical presentation
Local symptoms vs distant metastasis symptoms 0.62
Pathological examination
Pure vs mix 0.56
Prior history adenocarcinoma of the prostate
Yes vs no 0.75
Site of SCC
Local disease or bladder neck vs retroperitoneal
lymphnodes or distant metastasis 0.01
Chemotherapy (EP or IP)
Received vs not received 0.15
Radiotherapy
Received vs not received 0.001
SCC : small cell carcinoma, EP : VP-16＋CDDP or CBDCA,











































































腺小細胞癌に対する 66 Gy の放射線療法施行症例の
剖検例において原発巣での前立腺小細胞癌が消失して
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Table 3. Clinical outcomes of the patient
Variable
Rx (＋) Rx (−) Chi-
square
test
EP or IP (＋) EP or IP (−)
Chi-square test
No (％) No (％) No (％) No (％)
Age at diagnosis of SCC
21-50 1 ( 3) 2 ( 4) 3 ( 6) 0 ( 0)
51-60 3 (10) 6 (14) 6 (12) 3 (14)
61-70 8 (31) 9 (21) 11 (22) 6 (27)
71-85 17 (58) 25 (59) 0.81 29 (59) 13 (58) 0.62
PSA at diagnosis of SCC
With normal range 16 (55) 28 (68) 31 (65) 13 (59)
4-20 5 (17) 7 (17) 6 (13) 6 (27)
＞20 3 (10) 3 ( 7) 4 ( 8) 2 ( 9)
Unknown 5 (17) 3 ( 7) 0.55 7 (15) 1 ( 5) 0.32
Pathological examination
Pure 22 (76) 33 (79) 39 (80) 16 (73)
Mix 7 (24) 9 (21) 0.78 10 (20) 6 (27) 0.52
Site of SCC
Local of disease 4 (14) 3 ( 7) 6 (12) 1 ( 5)
Bladder neck 4 (14) 3 ( 7) 5 (10) 2 ( 9)
Retroperitoneal lymph nodes 9 (31) 3 ( 7) 8 (16) 4 (18)
Distant metastasis 12 (41) 33 (78) 0.01 30 (61) 15 (68) 0.74


















前立腺小細胞癌における MRI 画像は，T2 強調画
像でびまん性に低信号を示すことが特徴的な所見であ
る11)．本症例では，化学療法，および放射線治療後
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